Levels of mycophenolic acid and its glucuronide derivative in the plasma of liver, small bowel and kidney transplant patients receiving tacrolimus and cellcept combination therapy
- 1 June 2000
- journal article
- research article
- Published by Elsevier in Transplant Immunology
- Vol. 8 (2) , 143-146
- https://doi.org/10.1016/s0966-3274(00)00012-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findingsTransplant Immunology, 1997
- Mycophenolate mofetil rescue therapy in liver transplant recipientsTransplantation Proceedings, 1997
- High-performance liquid chromatographic method for the determination of mycophenolate mofetil in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- RS-61443—A PHASE I CLINICAL TRIAL AND PILOT RESCUE STUDY 1Transplantation, 1992
- Lymphocyte‐Selective Antiproliferative and Immunosuppressive Effects of Mycophenolic Acid in MiceScandinavian Journal of Immunology, 1991
- Lymphocyte‐Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide DepletionScandinavian Journal of Immunology, 1991
- Bioavailability Improvement of Mycophenolic Acid Through Amino Ester DerivatizationPharmaceutical Research, 1990